Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia

One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Zhiheng, Dai, Yifeng, Zeng, Tiansheng, Liu, Yan, Cui, Longzhen, Qian, Tingting, Si, Chaozeng, Huang, Wenhui, Pang, Ying, Ye, Xu, Shi, Jinlong, Fu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105742/
https://www.ncbi.nlm.nih.gov/pubmed/32266153
http://dx.doi.org/10.3389/fonc.2020.00379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105742/
https://www.ncbi.nlm.nih.gov/pubmed/32266153
http://dx.doi.org/10.3389/fonc.2020.00379

Ejemplares similares